News

Filter

Current filters:

Oracea

1 to 9 of 74 results

Strong generics sales see profit soar for IMPAX

06-05-2009

US drugmaker IMPAX Laboratories' profit rocketed for the first quarter of 2009, compared to the same…

DoryxDoxycyclineDoxycycline HyclateMonodoxOraceaRenvelaSevelamer Carbonate

Mylan group sued over for first-to-file ANDAs

27-03-2009

US generic drug major Mylan says that it and/or a subsidiary have been sued in connection with four separate…

DoxycyclineerlotinibEszopicloneFosrenolGenentechLanthanum Carbonate Chewable TabletsLunestaMonodoxOraceaPfizerShireTarceva

Warner Chilcott gets FDA response to citizens petition

23-03-2009

Warner Chilcott says that it has received the US Food and Drug Administration's response to its citizen…

DoryxDoxycyclineDoxycycline HyclateMayne PharmaMonodoxOracea

Patent suit filed in USA over Doryx generic

12-01-2009

IMPAX Laboratories says that Warner Chilcott Laboratories Ireland Limited, Warner Chilcott Company Inc,…

AtridoxDoryxDoxycyclineDoxycycline HyclateMonodoxOraceaPeriostatSumycinTetracyclineVibramycin Intravenous

Switzerland's Galderma in $420 million deal to acquire CollaGenex Pharma

03-03-2008

Swiss dermatological pharmaceutical specialty group Galderma Pharma says it has entered into a definitive…

CortenemaDoxycyclineHydrocortisoneHydrocortisone Cream and Ointment 2.5%Oracea

EMEA delays Oracea ruling until 2008

06-08-2007

German biotechnology company MediGene AG says it has been informed by USA-based CollaGenex Pharmaceuticals…

CollaGenex PharmaceuticalsDoxycyclineMonodoxOracea

Mylan gains final FDA OK for doxycycline 15mg ANDA

18-06-2007

Mylan Laboratories says that its Mylan Pharmaceuticals subsidiary has received final approval from the…

AdoxaDoxycyclineDoxycyline CapsulesMonodoxMylan LaboratoriesOracea

1 to 9 of 74 results

COMPANY SPOTLIGHT

Menarini

Back to top